药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

未开盘 02-02 16:08:06

60.100

-2.700

-4.30%

最高62.800	最低59.300	成交量600.55万
今开62.800	昨收62.800	日振幅5.57%
总市值756.06亿	流通市值756.06亿	总股本12.58亿
成交额3.64亿	换手率0.48%	流通股本12.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":60.1,"timestamp":1770019686003,"preClose":62.8,"halted":0,"volume":6005520,"delay":0,"changeRate":-0.04299363057324834,"floatShares":1258000000,"shares":1258000000,"eps":1.0041856381428405,"marketStatus":"未开盘","change":-2.7,"latestTime":"02-02 16:08:06","open":62.8,"high":62.8,"low":59.3,"amount":363516531,"amplitude":0.055732,"askPrice":60.15,"askSize":13500,"bidPrice":60.05,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":1.1482875171072668,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1770082200000},"marketStatusCode":0,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":62.8,"openAndCloseTimeList":[[1769995800000,1770004800000],[1770008400000,1770019200000]],"volumeRatio":1.462259,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2607509780","title":"药明合联01月30日主力净流出87.3万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607509780","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607509780?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:15","pubTimestamp":1769760914,"startTime":"0","endTime":"0","summary":"01月30日, 药明合联股价跌2.56%，报收62.80元，成交金额4.0亿元，换手率0.51%，振幅3.72%，量比1.91。药明合联今日主力资金净流出87.3万元，上一交易日主力净流入289.4万元。该股近5个交易日下跌8.96%，主力资金累计净流出1294.8万元；近20日主力资金累计净流入3091.0万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161546a6bf3070&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260130161546a6bf3070&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2607803097","title":"每日卖空追踪 | 药明合联 01月29日卖空量成交14.7万股，卖空比例为4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607803097","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607803097?lang=zh_cn&edition=full","pubTime":"2026-01-29 16:30","pubTimestamp":1769675430,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月29日，跌1.45%，卖空量成交14.7万股，较上一交易日减少53.04%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129164013a6bae327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2607285957","title":"每日卖空追踪 | 药明合联 01月28日卖空量成交6.1万股，卖空比例为1.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607285957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607285957?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:30","pubTimestamp":1769589029,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月28日，跌0.91%，卖空量成交6.1万股，较上一交易日减少79.97%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164812a45f8c24&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128164812a45f8c24&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2607728557","title":"药明合联01月28日主力净流出383.1万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2607728557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607728557?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:15","pubTimestamp":1769588158,"startTime":"0","endTime":"0","summary":"01月28日, 药明合联股价跌0.91%，报收65.40元，成交金额3.0亿元，换手率0.37%，振幅2.65%，量比1.60。药明合联今日主力资金净流出383.1万元，上一交易日主力净流入252.9万元。该股近5个交易日下跌3.54%，主力资金累计净流出1102.7万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2567.4万元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162615a45f772c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260128162615a45f772c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2606241696","title":"每日卖空追踪 | 药明合联 01月26日卖空量成交6.05万股，卖空比例为1.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606241696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606241696?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:30","pubTimestamp":1769416229,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月26日，跌3.5%，卖空量成交6.05万股，较上一交易日减少82.56%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163929a6ad7626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126163929a6ad7626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2606824161","title":"药明合联01月26日主力净流出1366.8万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2606824161","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606824161?lang=zh_cn&edition=full","pubTime":"2026-01-26 16:15","pubTimestamp":1769415351,"startTime":"0","endTime":"0","summary":"01月26日, 药明合联股价跌3.50%，报收66.25元，成交金额2.1亿元，换手率0.26%，振幅3.20%，量比0.87。药明合联今日主力资金净流出1366.8万元，上一交易日主力净流入454.4万元。该股近5个交易日下跌3.55%，主力资金累计净流入506.5万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入1583.4万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162224a6ad6295&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126162224a6ad6295&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2606241659","title":"医药生物行业双周报：2026年JPM大会圆满落幕 中国创新药资产成为全球焦点","url":"https://stock-news.laohu8.com/highlight/detail?id=2606241659","media":"长城国瑞证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606241659?lang=zh_cn&edition=full","pubTime":"2026-01-26 00:00","pubTimestamp":1769356800,"startTime":"0","endTime":"0","summary":"估值方面，截至2026 年1 月23 日，医药生物行业PE为30.31x，估值下行，低于均值。本报告期，两市医药生物行业共有34 家上市公司的股东净减持21.25亿元。其中，2 家增持0.63 亿元，32 家减持21.89 亿元。大会期间，艾伯维与荣昌生物达成关于ADC 药物RC148 的重磅BD 交易，进一步验证了中国创新药资产的全球价值。头部跨国药企与中国创新药企之间授权合作正在从单一品种授权转向平台共建能力与中长期联合开发。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126191104a6ae1075&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260126191104a6ae1075&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","06978","BK1574","BK1141","02268","BK1161","SG9999014674.SGD"],"gpt_icon":0},{"id":"2605432936","title":"药明合联(02268)根据股份计划发行275.17万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2605432936","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605432936?lang=zh_cn&edition=full","pubTime":"2026-01-22 08:30","pubTimestamp":1769041839,"startTime":"0","endTime":"0","summary":"智通财经APP讯，药明合联(02268)发布公告，于2026年1月2日-1月21日，根据股份计划发行合计275.17万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1395925.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2605107963","title":"每日卖空追踪 | 药明合联 01月21日卖空量成交22.3万股，卖空比例为8.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605107963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605107963?lang=zh_cn&edition=full","pubTime":"2026-01-21 16:30","pubTimestamp":1768984231,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月21日，涨1.5%，卖空量成交22.3万股，较上一交易日减少60.5%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165427a444d46a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260121165427a444d46a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2605178039","title":"每日卖空追踪 | 药明合联 01月20日卖空量成交21.55万股，卖空比例为4.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605178039","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605178039?lang=zh_cn&edition=full","pubTime":"2026-01-20 16:30","pubTimestamp":1768897829,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月20日，跌3.33%，卖空量成交21.55万股，较上一交易日减少61.41%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165241a440495c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120165241a440495c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1141","SG9999014674.SGD","02268"],"gpt_icon":0},{"id":"2604999951","title":"大摩：药明合联提全购东曜药业-B 维持“增持”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2604999951","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604999951?lang=zh_cn&edition=full","pubTime":"2026-01-20 10:51","pubTimestamp":1768877472,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，药明合联(02268)提全购东曜药业-B(01875)，交易引起部分投资者对收购理据的疑问。大摩对药明合联评级为“增持”，目标价88港元。报告指，2025年上半年，东曜药业录得收入4.89亿元人民币(下同)，盈利400万元; 同期对比，药明合联的收入和盈利分别为27.01亿元及7.46亿元。过去，东曜药业专注于肿瘤药物，进入2020年代后，公司将资源重新配置，转型为以ADC(抗体-药物偶联物)为重点的CDMO模式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120105452a43f1232&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120105452a43f1232&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","01875"],"gpt_icon":0},{"id":"2603991833","title":"515亿温州富豪，28亿吞并苏州药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2603991833","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603991833?lang=zh_cn&edition=full","pubTime":"2026-01-16 21:42","pubTimestamp":1768570978,"startTime":"0","endTime":"0","summary":"温州医药首富李革，拿下一家同行。1月14日晚，他实控的药明合联，宣布将以现金要约方式，以31亿港元的估值，约合28亿人民币，控股东曜药业。李革的药明系较为慷慨，出价4港元/股，相较12月下旬2港元左右的股价，刚好溢价一倍，考虑部分购股权注销价为1.7665港元，其要约最高代价约27.9亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601163622167671.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601163622167671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0326950275.SGD","LU0052750758.USD","BK4139","LU0456827905.SGD","SG9999002463.SGD","LU0516423174.USD","IE00B0JY6N72.USD","BK1610","LU0456846285.SGD","LU0856984785.SGD","LU0140636845.USD","LU1242518931.SGD","LU0979878070.USD","02268","LU0516422440.USD","CDMO","LU0516422366.SGD","LU1688375341.USD","LU0516423091.SGD","LU0051755006.USD","LU0348735423.USD","LU1720050803.USD","LU0043850808.USD","BK1589","LU0348825331.USD","BK1576","02269","LU0823426480.USD","LU0823426308.USD","SG9999002562.SGD","LU2488822045.USD","LU0417516738.SGD","SG9999014674.SGD","LU0307460666.USD","BK1141","LU0588546209.SGD","BK1521","LU2039709279.SGD","LU0039217434.USD","LU0359201612.USD","LU0572944931.SGD","LU0417516902.SGD","LU0516422952.EUR","LU1794554557.SGD","LU0181495838.USD","LU0359202008.SGD","LU1242518857.USD","LU0708995583.HKD","LU0327786744.USD","LU3063872942.SGD"],"gpt_icon":0},{"id":"2603954830","title":"一哥”3年砸100亿圈地，千亿市场正在“变天","url":"https://stock-news.laohu8.com/highlight/detail?id=2603954830","media":"新浪财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603954830?lang=zh_cn&edition=full","pubTime":"2026-01-16 09:49","pubTimestamp":1768528160,"startTime":"0","endTime":"0","summary":"这一收购价较东曜药业2025年12月22日收盘价溢价99%，较过去30个交易日平均收盘价更是溢价114.67%。其二，强化市场地位。从“拼价格”到“拼体系”中国的ADC CDMO，正在“变身”。皓元医药2025年前三季度前端业务营收14.5亿元，同比增长31%，后端业务营收6亿元，同比增长16.9%。其承接的XDC项目超70个，截至2025年6月，在22家ADC出海的国内公司中，服务了95%以上出","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116095150a4c9c462&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","02268","BK1191","BK1141","LU2488822045.USD","06821","01875"],"gpt_icon":0},{"id":"2603937939","title":"2026年JPM大会诺华、阿斯利康、辉瑞等巨头超百亿美元交易频现，中国资产成最大赢家","url":"https://stock-news.laohu8.com/highlight/detail?id=2603937939","media":"药厂那点事儿","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603937939?lang=zh_cn&edition=full","pubTime":"2026-01-16 07:05","pubTimestamp":1768518317,"startTime":"0","endTime":"0","summary":"巨头交易频现，中国资产备受青睐。诺华公司周二下午宣布了一项针对中国生物技术公司泽璟生物的许可交易。再生元计划在2026年公布该药用于肥胖治疗的中国3期临床试验结果，并启动全球3期临床开发计划。截至2025年第三季度，19家大型制药公司现金储备总额超过1700亿美元，2025年前三季度产生了约1400亿美元的自由现金流，为大规模并购交易提供了充足的资金支持。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116070908a4c93942&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09688","AAPG","06855","02269","BK1574","02359","ZLAB","02615","01477","BK1161","01530","06978","BK1191","02268"],"gpt_icon":0},{"id":"2603982881","title":"药明系再扩产能，溢价一倍收购上市药企","url":"https://stock-news.laohu8.com/highlight/detail?id=2603982881","media":"健识局","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603982881?lang=zh_cn&edition=full","pubTime":"2026-01-15 20:30","pubTimestamp":1768480210,"startTime":"0","endTime":"0","summary":"1月14日晚，药明系几家上市公司抛出一份联合公告：药明合联以现金每股4港元的价格，向东曜药业提出全面收购要约。消息发布后，1月15日，东曜药业股价大幅拉升最高77%。另外，截至去年上半年，东曜药业新增14个ADC项目，累计至169个项目。当然，药明合联已经未雨绸缪，表示收购完成后，继续维持东曜药业的上市地位。但同时，也将持续检讨东曜药业的营运，保留对公司业务和营运作出认为必要或适当的任何变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115203521a71eaac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115203521a71eaac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","BK1141","01875","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2603414670","title":"每日卖空追踪 | 药明合联 01月15日卖空量成交32.25万股，卖空比例为5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603414670","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603414670?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:30","pubTimestamp":1768465829,"startTime":"0","endTime":"0","summary":"药明合联北京时间01月15日，跌3.76%，卖空量成交32.25万股，较上一交易日减少49.37%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164042a4c6d327&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115164042a4c6d327&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","BK1141","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0},{"id":"2603867929","title":"31亿港元！药明合联拟溢价99%收购东曜药业，ADC产能有望进一步拓展","url":"https://stock-news.laohu8.com/highlight/detail?id=2603867929","media":"澎湃新闻","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603867929?lang=zh_cn&edition=full","pubTime":"2026-01-15 15:13","pubTimestamp":1768461189,"startTime":"0","endTime":"0","summary":"国内CXO行业再现大手笔收购。1月14日晚间，药明生物（2269.HK）、药明生物附属公司药明合联（2268.HK）及东曜药业（1875.HK）发布联合公告称，药明合联通过财务顾问花旗环球金融亚洲有限公司，向东曜药业发出自愿有条件现金要约，拟收购其全部已发行股份（要约人及一致行动人士已持有或同意收购的股份除外），并注销全部尚未行使购股权。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620361651.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620361651.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4080","BK4231","LU2488822045.USD","SG9999014674.SGD","BK1141","ADC","02268"],"gpt_icon":0},{"id":"2603676889","title":"港股药企接连开启并购，药明合联拟吞下东曜药业","url":"https://stock-news.laohu8.com/highlight/detail?id=2603676889","media":"第一财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603676889?lang=zh_cn&edition=full","pubTime":"2026-01-15 14:25","pubTimestamp":1768458352,"startTime":"0","endTime":"0","summary":"在中国生物制药宣布全资收购小核酸创新药企赫吉亚后的第二天，港股药企的又一起并购接踵而至。1月14日晚间，药明合联（02268.HK）发布了拟溢价约99%要约收购东曜药业消息。要约收购价每股为4港元，要约收购达成的条件之一，收购的股份可以使得药明合联持有东曜药业的投票权不低于60%。药明合联这次要约收购，将最高耗资27.9亿港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202601153620324032.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"a4cd798a0dc63451f8e31d3f6cbd021e","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601153620324032.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","02268","LU2488822045.USD","SG9999014674.SGD"],"gpt_icon":0},{"id":"2603626967","title":"【券商聚焦】交银国际：JPM医药大会有望继续催化板块行情","url":"https://stock-news.laohu8.com/highlight/detail?id=2603626967","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603626967?lang=zh_cn&edition=full","pubTime":"2026-01-15 09:09","pubTimestamp":1768439355,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周26省联盟药品集采开启，纳入多项国采可替代品种，该机构认为具备成本与渠道优势的头部企业将获益；同时两大进口主导型耗材省际联盟集采启动，国产替代进程有望进一步提速。JPM医药大会将于本周召开，超20家中国公司将出席并发表主题演讲，有望继续催化行情。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973261","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670628061.USD","LU0238689110.USD","LU2505996681.GBP","LU0215105999.USD","09939","IE00B5MMRT66.SGD","IE00BWXC8680.SGD","LU1116320737.USD","LU1719994722.HKD","LU1988902786.USD","01099","03329","02196","SG9999004311.SGD","LU1280957306.USD","LU0307460666.USD","LU0496365809.HKD","BK1197","LU0640798160.USD","BK1593","03933","LU1032466523.USD","LU1064131342.USD","LU0267386448.USD","IE00BN8TJ469.HKD","LU0942090050.USD","LU2357305700.SGD","LU0345770308.USD","LU2430703095.HKD","09926","BK4207","02268","LU0820561909.HKD","BK1515","LU1496350171.SGD","09688","LU2211815571.USD","BK1141","BK4581","LU0310799852.SGD","06160","01789","02367","LU0211327993.USD","01530","LU2592432038.USD","159938","LU0868494617.USD"],"gpt_icon":0},{"id":"2603462820","title":"智通港股早知道 | 财政部召开财政金融协同促内需会议 白宫宣布对特定半导体等加征25%关税","url":"https://stock-news.laohu8.com/highlight/detail?id=2603462820","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603462820?lang=zh_cn&edition=full","pubTime":"2026-01-15 07:40","pubTimestamp":1768434028,"startTime":"0","endTime":"0","summary":"参加会议的包括国务院有关部门和单位、省级财政部门、财政部各地监管局以及相关经办机构。美国白宫宣布对特定半导体等加征25%关税美国白宫14日宣布，从15日起对部分进口半导体、半导体制造设备和衍生品加征25%的进口从价关税。根据该通知书，市监总局已根据中华人民共和国反垄断法开始对本公司进行调查。经本公司财务部门初步测算，预计2025年度实现归属于上市公司股东的扣除","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a7a093e7059d2a399d631855b31ce739","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09961","BK1515","BK1247","BK1147","BK1502","09688","BK1584","BK1615","BK4588","TCOM","BK1501","SOXX","03759","BK1589","BK1610","SMH","ZLAB","01875","WXXWY","BK1591","BK1516","BK1564","BK1142","LU1720050803.USD","BK1617","02269","02268","LU1794554557.SGD","BK1521","BK1189","BK1571","BK4585","300759"],"gpt_icon":1}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":-0.0928},{"period":"1month","weight":-0.0204},{"period":"3month","weight":-0.1451},{"period":"6month","weight":0.0256},{"period":"1year","weight":1.1541},{"period":"ytd","weight":-0.0107}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0317},{"period":"6month","weight":0.0749},{"period":"1year","weight":0.3239},{"period":"ytd","weight":0.0447}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}